Fora Capital, LLC Kodiak Sciences Inc. Transaction History

Fora Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$81.97 - $106.94 $28,361 - $37,001	-346 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$77.2 - $126.54 $97,117 - $159,187	-1,258 Reduced 78.43%	346 $32 Million
Q1 2021 May 17, 2021	SELL	$110.45 - $164.47 $57,213 - $85,195	-518 Reduced 24.41%	1,604 $182 Million
Q4 2020 Feb 12, 2021	BUY	$60.78 - $154.03 $128,975 - $326,851	2,122 New	2,122 $311,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $417M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.